The protein Gpx-2 plays a vital role in inducing apoptosis in hepatocellular carcinoma cells (HCC cells) through lenvatinib therapy and serves as a biomarker for guiding treatment in HCC patients. Here, GPX2 is linked to hepatocellular carcinoma.